BAY1093884
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAY1093884, covering 2020-11-30 to 2020-11-30. Get the full timeline:
Most recent: Clinical Trial Update: Multiple Escalating Dose Study of BAY1093884 in Adults With Hemophilia A or B With or Without Inhibitors [Phase 2]